Phibro Animal Health (NASDAQ:PAHC – Get Rating) had its target price lowered by Barclays from $22.00 to $17.00 in a report released on Friday, The Fly reports. The firm currently has an underweight rating on the stock.
Several other equities research analysts have also commented on PAHC. TheStreet lowered shares of Phibro Animal Health from a b- rating to a c+ rating in a research note on Wednesday, August 24th. Morgan Stanley dropped their price target on shares of Phibro Animal Health from $23.00 to $21.00 and set an equal weight rating on the stock in a research note on Friday, August 26th.
Phibro Animal Health Price Performance
PAHC opened at $14.47 on Friday. The firm has a market cap of $586.09 million, a price-to-earnings ratio of 11.96 and a beta of 0.57. Phibro Animal Health has a fifty-two week low of $13.94 and a fifty-two week high of $22.96. The company’s 50-day moving average price is $17.75 and its 200 day moving average price is $18.75. The company has a quick ratio of 1.61, a current ratio of 2.97 and a debt-to-equity ratio of 1.59.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 28th. Stockholders of record on Wednesday, September 7th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 3.32%. The ex-dividend date of this dividend is Tuesday, September 6th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 39.67%.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. First Republic Investment Management Inc. boosted its holdings in shares of Phibro Animal Health by 6.7% in the second quarter. First Republic Investment Management Inc. now owns 13,276 shares of the company’s stock valued at $254,000 after acquiring an additional 836 shares in the last quarter. Martingale Asset Management L P boosted its holdings in shares of Phibro Animal Health by 3.4% in the second quarter. Martingale Asset Management L P now owns 30,640 shares of the company’s stock valued at $587,000 after acquiring an additional 1,017 shares in the last quarter. State of Tennessee Treasury Department boosted its holdings in Phibro Animal Health by 17.9% during the first quarter. State of Tennessee Treasury Department now owns 7,703 shares of the company’s stock worth $154,000 after buying an additional 1,167 shares in the last quarter. Credit Suisse AG boosted its holdings in Phibro Animal Health by 8.5% during the second quarter. Credit Suisse AG now owns 15,712 shares of the company’s stock worth $300,000 after buying an additional 1,236 shares in the last quarter. Finally, State of Alaska Department of Revenue boosted its holdings in Phibro Animal Health by 8.8% during the second quarter. State of Alaska Department of Revenue now owns 15,384 shares of the company’s stock worth $294,000 after buying an additional 1,240 shares in the last quarter. 50.97% of the stock is currently owned by institutional investors.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.
- Get a free copy of the StockNews.com research report on Phibro Animal Health (PAHC)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.